ProfileGDS5678 / 1428702_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 73% 73% 71% 73% 73% 76% 74% 72% 73% 73% 73% 73% 73% 74% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 14.7089273
GSM967853U87-EV human glioblastoma xenograft - Control 24.7301573
GSM967854U87-EV human glioblastoma xenograft - Control 34.5067271
GSM967855U87-EV human glioblastoma xenograft - Control 44.7857473
GSM967856U87-EV human glioblastoma xenograft - Control 54.6928573
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 14.9168476
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 24.7269674
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 34.6307472
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 44.782573
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 14.7286373
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 24.712873
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 34.7128673
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 44.7222973
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 54.8026274